Monthly Archives: August 2019

CLASS ACTION UPDATE for EGBN, NGHC and VAL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Eagle Bancorp, Inc. (NASDAQ:EGBN)

Lawsuit on behalf of: investors who purchased March 2, 2015 – July 17, 2019
Lead Plaintiff Deadline : September 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/eagle-bancorp-inc-loss-form?prid=3277&wire=1

According to the filed complaint, during the class period, Eagle Bancorp, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

National General Holdings Corp. (NASDAQ:NGHC)

Lawsuit on behalf of: investors who purchased August 6, 2015 – August 9, 2017
Lead Plaintiff Deadline : September 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/national-general-holdings-corp-loss-form?prid=3277&wire=1

According to the filed complaint, during the class period, National General Holdings Corp. made materially false and/or misleading statements and/or failed to disclose that: (a) National General was perpetrating a massive forced-placed CPI scheme to fraudulently saddle its own customers with unwanted and unneeded automobile insurance policies that it had underwritten; (b) National General’s illicit conduct in foisting unwanted and unneeded automobile insurance on its customers had resulted in some of the victims being declared delinquent, suffering adverse impacts to their creditworthiness, and/or having their cars improperly repossessed; (c) National General was exposed to an extreme risk of regulatory scrutiny, legal risks, and reputational harm as a result of its participation in the forced placed CPI scheme; (d) the Company had failed to maintain effective internal controls over its financial reporting, including by failing to maintain formal documentation sufficient to reasonably ensure the accuracy of internal reporting and accounting procedures across much of its business, including with respect to insurance policy premiums; (e) the Company’s reported quarterly revenues and policy premiums were in part the product of a fraudulent forced-placed insurance scheme and were therefore artificially inflated and unsustainable; and (f) National General had in fact lost substantial business with Wells Fargo because Wells Fargo had terminated the forced-placed CPI scheme after concluding that it posed excessive reputational risk and legal exposure.

Valaris plc (NYSE:VAL)

Lawsuit on behalf of: investors who purchased April 11, 2019 – July 31, 2019
Lead Plaintiff Deadline : October 21, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/valaris-plc-loss-form?prid=3277&wire=1

According to the filed complaint, during the class period, Valaris plc made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (iii) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 558021

Drivers Can Be Reimbursed by Car Insurance Companies in the Aftermath of Hurricane Dorian

LOS ANGELES, CA / ACCESSWIRE / August 30, 2019 / Compare-autoinsurance.org has launched a new blog post that explains how owners of vehicles damaged by hurricane Dorian can get reimbursed if they have the proper car insurance policy.

For more info and free auto insurance quotes, visit https://compare-autoinsurance.org/hurricanes-and-car-insurance/

Hurricanes and other extreme weather events can easily damage or even destroy a vehicle. Collision and comprehensive coverages will reimburse the drivers who got their vehicles damaged or destroyed during a hurricane. However, drivers who want their cars to be protected against the effects of a hurricane should purchase full coverage before the trajectory and the evolution of a hurricane are determined. Insurers can put temporary binding restrictions into effect in areas that are under a hurricane or tropical storm watch/warning. In most cases, the restrictions will go into effect as soon as an area goes into a tropical storm watch/warning and lasts until 48 to 72 hours after the watch/warning ends.

Drivers can be reimbursed for the damage done to a vehicle by a hurricane if they have the next coverages:

Collision coverage. Collision coverage is an optional car insurance policy that covers the cost of repairing or replacing a vehicle if it’s damaged in an accident. During a hurricane, the rain can make a vehicle to hydroplane and crash. In this type of cases, policyholders can file claims to be reimbursed. Drivers should avoid driving on wet roads, especially during a hurricane.
Comprehensive coverage. Comprehensive coverage can cover a vehicle in many different scenarios. During a hurricane, a vehicle can be affected in many different ways. Typically, a car gets damaged or destroyed during a hurricane in scenarios such as falling trees or branches, strong winds that can flip a vehicle, unsecured objects that hit a vehicle, wind damage, water damage, corrosion caused by saltwater exposure, mechanical damage caused by water exposure, and so on. Comprehensive insurance will cover all of these scenarios and even more, as long as the hurricane was the cause of damage.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

“Hurricanes are extremely dangerous weather phenomena that can easily destroy your vehicle. To protect your vehicle from the damage of a hurricane, you should purchase the proper coverage before the insurers place their restrictions”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Company Name: Internet Marketing Company
Person for contact Name: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 558018

Silver Spruce Grieves the Passing of Gordon H. Barnhill, CFO

BRIDGEWATER, NS / ACCESSWIRE / August 30, 2019 / (TSXV:SSE) Silver Spruce Resources Inc. (“Silver Spruce” or the “Company”) is deeply saddened by the passing of its longtime friend, collegue and CFO, Gordon Harold Barnhill. He passed away peacefully in the Halifax Infirmary, QEII, Halifax on August 28, 2019 at the age of 77. Gordon was dedicated to to his family and to professional excellence. He will be greatly missed. The Company extends its deepest condolences to his family and friends for our collective loss.

Gordon began his financial career with Trans Canada Credit and then worked for the Royal Bank for 28 years in both Nova Scotia and New Brunswick until his retirement. Not one to stand still too long, he then become the Chief Financial Officer for Silver Spruce Resources Inc. and continued working there until the time of his death. Gordon served on the board of directors for Big Brothers and Big Sisters Nova Scotia for several years. He was an avid salmon fisherman and hunter and has left behind many happy memories of salmon fishing on St. Mary’s River.

A funeral service will be held at 1 p.m. on Saturday, August 31st, in Bridgewater Baptist Church, 564 Glen Allan Dr., Bridgewater, Rev. Dr. Aaron Kenny officiating. Memorial donations, in lieu of flowers may be made to organizations close to Gordon’s heart; Big Brothers Big Sisters Canada and St. Mary’s River Association. Online condolences may be made by visiting: www.sweenysfuneralhome.com.

About Silver Spruce Resources Inc.

Silver Spruce Resources Inc. is a Canadian junior exploration company pursuing development of the Pino de Plata project, located in the prolific Sierra Madre Occidental region of western Chihuahua State in Mexico. The Company has signed a binding Letter of Agreement to acquire 100% of the advanced Cocula gold project in Jalisco State, Mexico. Silver Spruce Resources Inc. continues to investigate opportunities that Management has identified or that have been presented to the Company for consideration.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The company seeks Safe Harbour.

Contact:

Silver Spruce Resources Inc.
Karl Boltz, President/CEO/Director
(866) 641-3397
info@silverspruceresources.com
www.silverspruceresources.com

SOURCE: Silver Spruce Resources Inc.

ReleaseID: 558020

How to Recognize and Avoid Car Insurance Scams After Hurricane Dorian

LOS ANGELES, CA / ACCESSWIRE / August 30, 2019 / Compare-autoinsurance.org has launched a new blog post that explains how policyholders can recognize car insurance scams after Hurricane Dorian.

For more info and free quotes, please visit https://compare-autoinsurance.org/car-repair-scams-after-hurricanes/

After a hurricane, there are many dishonest individuals who take advantage of the situation to exploit the insurance companies and policyholders. These fraudsters, also known as “Storm Chasers”, will try to sell flood-damaged cars, or phony repair deals, while demanding an upfront payment. Many victims fall for this trap because the scammers offer low prices deals. In most cases, fraudsters will leave the town once they considered they scammed enough victims.

To avoid scams after a hurricane, drivers should follow the next tips:

Be careful with unsolicited inspections or vehicle repair offers. Policyholders are advised to avoid working with persons that were not hired or contracted to do a mechanical inspection or damage assessment. Individuals who are trying to sell a quick fix are likely to be fraudsters.
Do not make large upfront payments. If a contractor asks for a down payment that is more than 25% of the total cost., then drivers are advised to refuse it. Good contractors don’t take more than 10%, 25% of the total cost as a down payment.
Verify the contractor before the work begins. Before starting the work, policyholders should analyze some important details about the individuals they are about to hire for repairs. Drivers should check if they have offices, websites and they should look for reviews from previous customers. If the policyholders can’t find any info about these persons and the individuals refuse to provide any information as well, then the policyholders should refuse to work with them.
Check materials. Drivers should ensure that the contractor uses quality parts and not some shady aftermarket parts. Before hiring a contractor, drivers should inspect what kind of parts are going to be used.
Obtain a signed contract. Drivers should get a signed contract and keep it in a safe place. If it’s possible, drivers should get a contract that contains prices per labor and materials, repair procedures, and estimated start and finish dates.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

“After a hurricane, many shady individuals will appear promising a quick fix to your damaged vehicle. Before working with anyone, you should carefully check if these persons can be trusted”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Company Name: Internet Marketing Company
Person for contact Name: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 558019

African Rainbow Minerals Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / African Rainbow Minerals Ltd. (OTCPINK: AFRBY) will be discussing their earnings results in their 2019 Second Half Earnings to be held on August 30, 2019 at 3:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-60C95EF5284DF

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 557930

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dropbox, Inc. (DBX)

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dropbox, Inc.(“Dropbox” or the Company”) (NASDAQ:DBX). Investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/dbx.

The investigation concerns whether Dropbox and certain of its officers and/or directors have violated federal securities laws.

Dropbox raised $756,000,000 in new capital, selling 36 million shares of stock in its initial public stock offering (the “IPO”) priced at $21.00 a share around March 23, 2018. On August 8, 2019, Dropbox announced its 2019 second-quarter fiscal results, reporting a revenue of $410.4 million below analysts’ $420.3 million projection. Following this news, Dropbox stock dropped 12.8% on August 9, 2019. Since the IPO, Dropbox has dropped, and close at $17.80 on August 20, 2019.

If you are aware of any facts relating to this investigation, or purchased Dropbox shares,you can assist this investigation by visiting the firm’s site: www.bgandg.com/dbx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 558017

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OMCL, CARB and PS

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Omnicell, Inc. (NASDAQGS:OMCL)

Investors Affected : October 25, 2018 – July 11, 2019

A class action has commenced on behalf of certain shareholders in Omnicell, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company recognized revenue for certain transactions before fulfilling its performance obligations; (2) the Company engaged in improper accounting practices to meet revenue targets; (3) the Company experienced weaker demand for new product lines than it had previously projected; (4) as a result, the Company would be required to write-off certain inventory; (5) the Company misclassified certain expenses as capitalized expenditures; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/omnicell-inc-loss-submission-form/?id=3276&from=1

Carbonite, Inc. (NASDAQGM:CARB)

Investors Affected : February 7, 2019 – July 25, 2019

A class action has commenced on behalf of certain shareholders in Carbonite, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Carbonite’s Server Backup VM Edition was of poor quality and technologically flawed; (ii) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (iii) the poor quality and technological flaws of the Server Backup VM Edition was acting as a “disruptive” factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (iv) as a result of the foregoing, Carbonite lacked any reasonable basis for issuing its positive projections and financial forecasts.

Shareholders may find more information at https://securitiesclasslaw.com/securities/carbonite-inc-loss-submission-form/?id=3276&from=1

Pluralsight, Inc. (NASDAQGS:PS)

Investors Affected : August 2, 2018 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Pluralsight, Inc. According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering (“SPO”) that it was behind schedule onboarding new sales representatives, which was hurting the Company’s sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

Shareholders may find more information at https://securitiesclasslaw.com/securities/pluralsight-inc-loss-submission-form/?id=3276&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 558016

CLASS ACTION UPDATE for CAH, GVA and IFF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Cardinal Health, Inc. (NYSE:CAH)

Lawsuit on behalf of: investors who purchased March 2, 2015 – May 2, 2018
Lead Plaintiff Deadline : September 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cardinal-health-inc-loss-form?prid=3275&wire=1

According to the filed complaint, during the class period, Cardinal Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) following Cardinal’s acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis’s performance were never implemented across Cordis; 2) Cordis’s antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; 3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; 4) the Company materially overstated Cordis’s inventory balances; 5) Cordis was not “performing well” and its integration was not “on track,” “going incredibly well” or “largely on plan”; and 6) to correct Cordis’s deficiencies, the Company would have to make substantial investments in Cordis’s IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

Granite Construction Incorporated (NYSE:GVA)

Lawsuit on behalf of: investors who purchased October 26, 2018 – August 1, 2019
Lead Plaintiff Deadline : October 15, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/granite-construction-incorporated-loss-form?prid=3275&wire=1

According to the filed complaint, during the class period, Granite Construction Incorporated made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had assumed certain risks in connection with its heavy civil joint venture projects bid between 2012 and 2014; (2) there was an “untenable” imbalance of risk sharing between the Company and the joint venture project owners; (3) as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

International Flavors & Fragrances Inc. (NYSE:IFF)

Lawsuit on behalf of: investors who purchased May 7, 2018 – August 5, 2019
Lead Plaintiff Deadline : October 11, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/international-flavors-fragrances-inc-loss-form?prid=3275&wire=1

According to the filed complaint, during the class period, International Flavors & Fragrances Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 558015

CLASS ACTION UPDATE for RBGLY, NFLX and LB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Reckitt Benckiser Group plc (OTC PINK:RBGLY)

Lawsuit on behalf of: investors who purchased On behalf of all purchasers of Reckitt American Depositary Shares (“ADSs”) from July 28, 2014 through April 9, 2019
Lead Plaintiff Deadline : September 13, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/reckitt-benckiser-group-plc-loss-form?prid=3274&wire=1

According to the filed complaint, (a) defendants had engaged in a scheme to artificially inflate the sales of Suboxone Film by more than $3 billion by falsely touting the drug’s purportedly superior efficacy and safety as compared to tablets; (b) contrary to defendants’ public statements, the FDA and internal Company documents had concluded that Suboxone Film posed a potentially greater risk of abuse and child endangerment than other available treatments; (c) defendants had fabricated a safety scare involving Suboxone Tablets in order to unlawfully delay and prevent generic competition; (d) defendants had engaged in a massive marketing campaign that had misrepresented the purported benefits of Suboxone Film as compared to Suboxone Tablets to doctors, healthcare providers, government regulators and investors; (e) defendants had encouraged Suboxone sales through medical providers that they knew were overprescribing the drug, facilitating the drug’s abuse and/or prescribing it in a careless and clinically unwarranted manner, often to hundreds of individuals at a time; (f) as a result of (a)-(e) above, Reckitt’s revenues, net income an d earnings were artificially inflated and the product of illicit business practices; and (g) as a result of (a)-(f) above, Reckitt and Reckitt Pharma were exposed to extraordinary undisclosed legal and reputational risks that could result in billions of dollars in fines, lost business and legal judgments or other monetary penalties.

Netflix, Inc. (NASDAQ:NFLX)

Lawsuit on behalf of: investors who purchased April 17, 2019 – July 17, 2019
Lead Plaintiff Deadline : September 20, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/netflix-inc-loss-form?prid=3274&wire=1

According to the filed complaint, during the class period, Netflix, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

L Brands, Inc. (NYSE:LB)

Lawsuit on behalf of: investors who purchased May 31, 2018 – November 19, 2018
Lead Plaintiff Deadline : September 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/l-brands-inc-loss-form?prid=3274&wire=1

According to the filed complaint, during the class period, L Brands, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the Victoria’s Secret and PINK businesses were having a material adverse effect on the Company’s cash flow, liquidity and debt levels; (b) Defendants lacked a reasonable basis for their positive statements about the ability of the Company to sustain its dividend; (c) the MD&A disclosures in filings L Brands made with the SEC were materially false and misleading; (d) the risk factor disclosures in filings L Brands made with the SEC were materially false and misleading; (e) the representations about L Brands’ disclosure controls in filings the Company made with the SEC were materially false and misleading; (f) the certifications issued by Defendants Wexner and Burgdoerfer on L Brands disclosure controls were materially false and misleading; and (g) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about L Brands’ then-current business operations and future financial
prospects.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 558014

Orthobiologics Market Size, Global Growth, Key Regions, Segments, Top Trends, Fervent Players, Demand and Forecast to 2023

Global Orthobiologics Market Information by Product, Application, by End User and Region – Forecast till 2024

Pune, India – August 30, 2019 /MarketersMedia/

Top Players:

Some of the key players in the global orthobiologics market are Arthrex, Inc., Exactech, Inc., Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries, Inc., NuVasive, Inc., Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, and Others

Orthobiologics are derived from the human body and used by surgeons for treating injuries. It helps in easy recovery and healing of wounds. It can be useful for treating broken bones and injured muscles, tendons, and ligaments. The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global Orthobiologics market during the forecast period.

Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US. Also, 24.5% of women 65 years of age and over have a lumbar spine in US.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7826

The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.

Segmentations

The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.

Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.

Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.

Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.

Regional Analysis:

The market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.

Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.

The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market. The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.

The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope Of The Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

Continued…

Access Full Report at https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

Source URL: https://marketersmedia.com/orthobiologics-market-size-global-growth-key-regions-segments-top-trends-fervent-players-demand-and-forecast-to-2023/88913899

Source: MarketersMedia

Release ID: 88913899